Cargando…
Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
Autores principales: | Garcia-Arellano, Gisela, Camacho-Ortiz, Adrian, Moreno-Arquieta, Ilse Andrea, Cardenas-de la Garza, Jesus Alberto, Rubio-Torres, Diana Carolina, Garza-Gonzalez, Elvira, Bocanegra-Ibarias, Paola, Galarza-Delgado, Dionicio Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632263/ https://www.ncbi.nlm.nih.gov/pubmed/36335994 http://dx.doi.org/10.1016/j.amjms.2022.10.012 |
Ejemplares similares
-
Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998) -
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study
por: Esquivel-Valerio, Jorge Antonio, et al.
Publicado: (2021) -
Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022) -
Supratentorial Listeria monocytogenes Brain Abscess in a Patient with Liver Cirrhosis
por: Flores-Perez, Romulo Omar, et al.
Publicado: (2020) -
The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance
por: Bocanegra-Ibarias, Paola, et al.
Publicado: (2019)